Veradigm Stock Price, News & Analysis

Veradigm (OTCMKTS: MDRX) has launched seven new disease-specific cardiometabolic Clinical Data Registry datasets to enhance real-world research capabilities. The registries harmonize data from over 80 different electronic health records (EHRs), combining both structured and unstructured data to provide comprehensive insights into disease patterns and treatment outcomes.

The new registry cohorts include specialized datasets for Heart Failure, Atrial Fibrillation, ASCVD, Hypertension, Type 1 Diabetes, Type 2 Diabetes, and Chronic Kidney Disease. The company utilizes Natural Language Processing (NLP) to extract insights from clinical data, particularly focusing on details relevant to life science researchers, public health, and government regulators.

Veradigm (OTCMKTS: MDRX) has achieved top rankings in Black Book Research's 2025 Top-Rated EHR Vendors by Specialty, securing the #1 position for both Ambulatory EHR Family Practice and Primary Care General Practice categories. The recognition follows a comprehensive nine-month survey involving 33,516 respondents across the United States.

The company's EHR solution received exceptional scores, achieving a 9.3 out of 10 (93% client experience rating), particularly excelling in ease of navigation and telehealth integration. The platform serves tens of thousands of providers nationwide and has recently launched Veradigm Ambient Scribe to further enhance provider experience.

Black Book's evaluation highlighted Veradigm's success in adapting to regulatory changes, improving interoperability, enhancing patient engagement, and streamlining practice workflows. The recognition validates Veradigm's commitment to transforming healthcare through innovative solutions that address provider burnout and support the transition to value-based care.

Veradigm (OTCMKTS: MDRX) announced that Beth Altman resigned from the Board of Directors on January 28, 2025, citing health reasons. Her departure is unrelated to any disagreements with company operations, policies, or practices and does not affect the ongoing restatement of 2022 financial statements.

Following Altman's resignation, who served as Audit Committee Chair since 2020, the Board appointed Greg Garrison as interim Audit Committee Chair. Garrison previously held this position from May 2016 through June 2022. The company is actively seeking stockholder input to identify qualified candidates for Board positions.

Veradigm (OTCMKTS: MDRX) announced the integration of new datasets into its Veradigm Network EHR (VNEHR) Data, one of the largest ambulatory electronic health record databases with over 154 million unique patients. The enhancement includes social determinants of health (SDoH) and mortality data, enabling deeper research insights.

The integration addresses the challenge that 80% of critical patient information is typically locked within unstructured data. Using advanced natural language processing (NLP) technology, VNEHR Data now provides research-ready, de-identified data optimized for life science, public health, and academic research.

The new NLP-derived SDoH data includes socioeconomic, environmental, and behavioral factors such as income levels, education, housing stability, and social support. The mortality data addition aims to enhance real-world evidence generation, support post-market surveillance, and improve drug development through better identification of at-risk populations.

Veradigm (OTCMKTS: MDRX) has launched Veradigm Ambient Scribe, an AI-powered platform designed to reduce healthcare providers' documentation burden. The solution automatically captures and transcribes patient-provider interactions into structured medical notes that integrate with Veradigm EHR. This advancement aims to increase operational efficiency and enhance patient care by allowing clinicians to focus more on patient interactions and less on data entry. The platform, powered by AvodahMed™, joins Veradigm's portfolio of solutions designed to streamline healthcare administrative tasks.

Veradigm (OTCMKTS: MDRX) announced an enhanced strategic collaboration with Insiteflow to expand Veradigm Payer Insights (VPI) beyond its current EHR footprint. The partnership extends VPI to additional EHR platforms, including Epic, enabling real-time delivery of payer insights directly into healthcare provider workflows.

The collaboration, which began in 2022, integrates care gaps alerts and patient condition recommendations to improve care coordination and clinical outcomes. The system now works across multiple EHR platforms, including Veradigm EHR and Practice Fusion, supporting payer-provider collaboration and advancing value-based care initiatives.

Veradigm (OTCMKTS: MDRX) has announced the complete integration of advanced natural language processing (NLP) into its electronic health record (EHR) dataset. This enhancement allows for deeper clinical insights from unstructured EHR data, combined with structured data to create regulatory-grade, real-world data (RWD) for research purposes.

The Veradigm Network EHR Data is sourced from over 154 million unique patient records, making it one of the most comprehensive ambulatory databases in the United States. It encompasses over five billion distinct patient notes from multiple EHR systems and specialties, collected over a rolling five-year period.

Veradigm's NLP models, developed by clinicians and data scientists, extract important clinical insights into structured data tables. This integration offers researchers valuable insights into therapy decisions, disease progression, and patient outcomes, supporting clinical trials, regulatory submissions, and safety studies.

Veradigm (OTCMKTS: MDRX) has announced that over 300,000 healthcare providers across the United States are now using its automated medical chart retrieval solution, Veradigm eChart Courier. This milestone highlights the increasing demand for solutions that enhance efficiency, reduce administrative burdens, and facilitate seamless connections between healthcare providers and payers.

The eChart Courier solution automates the medical chart retrieval process, saving time, resources, and expenses for both providers and health plans. It securely delivers medical records via electronic transfer and presents clinical data to health plans in an easily analyzable format.

Tom Langan, Interim CEO, President and Chief Commercial Officer of Veradigm, emphasized the company's commitment to helping healthcare stakeholders control costs and optimize health outcomes through innovative tools like eChart Courier. Keri Straub of Clinix Center for Health praised the solution for improving efficiency, reducing paperwork, enhancing compliance with health plan requirements, and allowing clinical teams to focus more on patient care.

Veradigm (OTCMKTS: MDRX), a leading healthcare data and technology solutions provider, has been ranked as the top vendor for broad retrospective vendors in KLAS's Risk Adjustment 2024 report. The report highlighted the increasing demand for comprehensive risk adjustment solutions, including both retrospective and prospective capabilities.

Veradigm clients reported strong satisfaction with the company's suite of solutions, making it the most recommended vendor. Clients interviewed by KLAS noted significant outcomes, including increased ROI from retrospective risk adjustment solutions, more reliable submissions, and comprehensive validation processes.

Veradigm's risk adjustment solutions offer a full spectrum of services for health plans, supporting them in achieving operational goals and improving financial performance.